Fleur Hudson - Concepedia

Author

Fleur Hudson

Also Known As

Abdel G. Babiker, Adam Cursley, Andrew Gregory, Ann Sarah Walker, Anne Hoppe, B Aagaard, Elizabeth C George, Eron, J.J., F Hudson, F Parker Hudson

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

University College London MRC Clinical Trials Unit at UCL Medical Research Council UNSW Sydney University of Minnesota

About

Fleur Hudson is an author at University College London specializing in medicine, clinical trials, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	2.4K
2	Public Health	2	2	155
3	Health Sciences	1	1	17
4	Cell Biology	1	1	76
5	Emergency Medicine	1	1	19

Fleur Hudson

Publications

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial Stephen R. Russell, Jean Bennett, Jennifer Wellman, The Lancet Ocular DiseaseRetinaOphthalmologyExperimental OphthalmologyVoretigene Neparvovec	2017	1.8K
Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial John Collinge, Michele Gorham, Fleur Hudson, The Lancet Neurology	2009	259
Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial François Raffi, Abdel G. Babiker, Laura Richert, The Lancet Treatment And PreventionAntiviral Drug DevelopmentClinical TrialsAntiviral TherapyVirology	2014	172
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial Sarah Fidler, Wolfgang Stöhr, Lucy Dorrell, The Lancet Antiretroviral TherapyHiv/aids CounsellingTreatment And PreventionAntiviral TherapyHiv Reservoir	2020	135
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial Thomas L Holland, Adit A. Ginde, Roger Paredes, The Lancet Respiratory Medicine Covid-19 PandemicAntiviral TherapyClinical TrialsCovid-19 EpidemiologyMedicine	2022	124
Analysis of Hypomorphic KitlSl Mutants Suggests Different Requirements for KITL in Proliferation and Migration of Mouse Primordial Germ Cells1 Aparna Mahakali Zama, Fleur Hudson, Mary A. Bedell Biology of Reproduction Different RequirementsGeneticsMolecular GeneticsKit LigandCell Specialization	2005	76
A randomized trial comparing concise and standard consent forms in the START trial Christine Grady, Giota Touloumi, A. Sarah Walker, PLoS ONE	2017	47
Occurrence of Accelerated Epigenetic Aging and Methylation Disruptions in Human Immunodeficiency Virus Infection Before Antiretroviral Therapy Chen Xi Yang, E Schön, Ma’en Obeidat, The Journal of Infectious Diseases	2020	42
DNA methylation is associated with airflow obstruction in patients living with HIV Ana I. Hernández Cordero, Chen Xi Yang, Ma’en Obeidat, Thorax	2020	38
PRION-1 scales analysis supports use of functional outcome measures in prion disease Simon Mead, Michael Rañopa, Gosala Gopalakrishnan, Neurology	2011	31

Page 1